Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab

<div>Concentration of the inhibitor (<span class="nowrap"><svg height="8.68572pt" id="M144" style="vertical-align:-0.0498209pt" version="1.1" viewbox="-0.0498162 -8.6359 5.68448 8.68572" width="5.68448pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M405 650H141L135 622C222 616 230 610 215 535L133 116C118 41 113 33 29 28L23 0H289L295 28C209 33 205 40 219 116L298 535C312 609 317 616 399 622L405 650Z"></path></g></svg>)</span> in the case of various therapies on two different scales.</div>

Complexity

fig5

Figure 5

Figure 5: Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab 